Story perspectives
Conservatives Unite Against Trump’s MFN Drug Pricing Policy
2/13/2026
1 of 1
Story summary
- A coalition of over 50 conservative leaders signed a letter opposing U.S. President Donald Trump's MFN drug pricing policy.
- They argue MFN would impose socialist price controls and harm U.S. competitiveness.
- They say MFN would not fix foreign freeloading or improve healthcare.
- Signatories include Grover Norquist (conservative activist) and Stephen Moore (conservative economist), who warn of reduced innovation and shortages.
